Trademark: 87878311
Word
NEUVAX
Status
Registered
Status Code
700
Status Date
Tuesday, January 18, 2022
Serial Number
87878311
Registration Number
6622822
Registration Date
Tuesday, January 18, 2022
Mark Type
4000
Filing Date
Monday, April 16, 2018
Published for Opposition
Tuesday, September 11, 2018

Trademark Owner History
SELLAS Life Sciences Group, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations and vaccines for the treatment of cancer

Trademark Events
Jan 18, 2022
Registered-Principal Register
Dec 11, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 10, 2021
Allowed Principal Register - Sou Accepted
Oct 27, 2021
Statement Of Use Processing Complete
Oct 21, 2021
Use Amendment Filed
Oct 21, 2021
Teas Statement Of Use Received
Apr 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2021
Extension 5 Granted
Apr 13, 2021
Extension 5 Filed
Apr 27, 2021
Case Assigned To Intent To Use Paralegal
Apr 13, 2021
Teas Extension Received
Nov 5, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 3, 2020
Extension 4 Granted
Nov 3, 2020
Extension 4 Filed
Nov 3, 2020
Teas Extension Received
Apr 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 7, 2020
Extension 3 Granted
Apr 7, 2020
Extension 3 Filed
Apr 7, 2020
Teas Extension Received
Oct 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2019
Extension 2 Granted
Oct 17, 2019
Extension 2 Filed
Oct 17, 2019
Teas Extension Received
May 8, 2019
Notice Of Approval Of Extension Request E-Mailed
May 6, 2019
Extension 1 Granted
May 6, 2019
Extension 1 Filed
May 6, 2019
Teas Extension Received
Nov 6, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 11, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2018
Published For Opposition
Aug 22, 2018
Notification Of Notice Of Publication E-Mailed
Aug 4, 2018
Approved For Pub - Principal Register
Aug 3, 2018
Assigned To Examiner
Apr 23, 2018
New Application Office Supplied Data Entered In Tram
Apr 19, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24